 "SIRO Clinpharm Improves R&D Efficiency With Oracle")
SIRO Clinpharm (SIRO), an India-based independent, full-service clinical research organisation (CRO) is using Oracle clinical applications to improve R&D efficiency and customer responsiveness. Established in 1996, SIRO offers end-to-end clinical research services, with clinical trials management and clinical data management as its core operations. SIRO required a best-in-class solution that was robust and could rapidly scale to meet the company’s growth demands. Oracle’s clinical applications are helping SIRO speed up information gathering and reduce the need for paper documentation.
“We have been growing at an aggressive rate for the last three years. To sustain our aggressive growth plans, we are looking at both organic and inorganic growth options across the globe. Oracle’s clinical applications are helping us achieve this by delivering a powerful combination of technology and comprehensive business applications, and key functionality built specifically to address the nuances of the CRO industry,” said Dr Chetan Tamhankar, chief operating officer, SIRO Clinpharm.
Oracle’s clinical applications are designed to enable CROs to improve R&D efficiency by enhancing operational efficiencies and outcomes in clinical trial management; increasing efficiency and quality of clinical data with electronic data capture; streamlining analysis, reporting and submission of integrated clinical and non-clinical data; and improving clinical trial decision-support with clinical analytics.
Oracle’s integrated suite of applications and infrastructure software for clinical development includes Oracle Clinical, Oracle Remote Data Capture, Oracle Thesaurus Management System, Oracle Adverse Event Reporting System, Oracle Life Sciences Data Hub, and Oracle’s Siebel Clinical Trial Management System. These solutions provide a streamlined system for managing large volumes of patient data collected during clinical trials.
Industry experts estimate that by 2011, India’s CRO industry market size will reach $1 billion. The success of the CRO business model is heavily reliant on project, trial and data management, and thus, clinical applications will have a major role to play in this growth.